Karyopharm Therapeutics (KPTI) Q1 2026 Earnings

12FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-5.71
-4.47
-3.23
-1.99

Details

Expected EPS
-1.994286
Actual EPS
-5.71
Surprise EPS
-3.72
Surprise Percent
+186.32%

Description

Karyopharm Therapeutics (KPTI) has reported earnings of -5.71 per share for Q1 2026.

0 Comments

Share your thoughts